Table 7.
Predictive Accuracy of Different Bleeding Definitions for 30‐Day Mortality
VARC‐2 (LT) | BARC (Class ≥3) | BARC (Class ≥2) | TIMI (Major) | TIMI (Major+Minor) | GUSTO (Severe or LT) | GUSTO (Severe or LT and Moderate) | Modified VARC (LT) | BARC (Class ≥3) P Value | BARC (Class ≥2) P Value | TIMI (Major) P Value | TIMI (Major+Minor) P Value | GUSTO (Severe or LT) P Value | GUSTO (Severe or LT and Moderate) P Value | Modified VARC (LT) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sensitivity | 36% | 50% | 50% | 32% | 50% | 25% | 43% | 54% | 0.13 | 0.13 | 1.00 | 0.13 | 0.25 | 0.50 | 0.063 |
Specificity | 89% | 80% | 75% | 90% | 80% | 98% | 85% | 85% | <0.001 | <0.001 | 0.25 | <0.001 | <0.001 | 0.001 | <0.001 |
Accuracy | 86% | 78% | 73% | 87% | 78% | 93% | 83% | 83% | 0.49 | 1.00 | 0.42 | 0.47 | 0.71 | 0.55 | 0.064 |
Data are percentages. Reference group for comparison of sensitivity, specificity: VARC2 LT. P value for Ho: equality of sensitivity/specificity. BARC indicates Bleeding Academic Research Consortium; GUSTO, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries investigators; LT, life‐threatening; TIMI, Thrombolysis in Myocardial Infarction investigators; VARC, Valve Academic Research Consortium.